Research and Markets (http://www.researchandmarkets.com/research/t9fc24/chimeric_antigen) has announced the addition of the "Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2016" report to their offering.

The report, Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2016 emphasizes on the currently active CAR-T cell products in research and development.

The Report covers the 40+ companies which are active in this field including 27 leading companies with 101 products targeting 44 different antigens and 24 different technologies. The Report provides in-depth analysis on the CAR-T cell profiles covering pre-clinical and clinical studies, Collaborations details and Deal values, Technologies and Targeted antigens.

The Report provides the CAR-T licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis. Report also describes the unmet needs covered by CAR-T cells highlighting the adverse events, which are major concerns in the market for the usage of CAR-T cells.

Report Highlights:

- CAR-T cell Therapy Pipeline scenario

- Collaborations & partnering deals

- Current Prominent Research Areas and Key Players

- Pipeline product profiles CAR-T Technologies and Targeted Antigens

- Licensing opportunities

- Market Drivers and Barriers

Key Topics Covered:

1 Report Introduction

2 Executive Summary Snapshot

3 Executive Summary

4 Introduction

5 CAR-T Cell Therapy-Analysis

6 Pipeline Profiles

7 Upcoming Technologies Better than CARs

8 Market Drivers

9 Market Barriers

10 SWOT Analysis

11 Report Methodology

12 Consulting Services

For more information visit http://www.researchandmarkets.com/research/t9fc24/chimeric_antigen